Please note that we have stopped the regular imports of Gene Expression Omnibus (GEO) data into ArrayExpress. This may not be the latest version of this experiment.
E-GEOD-51130 - Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance
Released on 22 July 2014, last updated on 26 July 2014
Original patient tumor is directly implanted in mice xenografts. Tumor is propagated to multiple mice for conduct of 6 arm treatment trials and control. Therapies are selected based on T0 and F0 genomic profiles. ICE-T refractory tumor are implanted and additional 6 arm treatment trial and control conducted based on genomic profiles of F2 generation mice to suggested therapies Original patient tumor expanded in F0 mouse generation to F1 generation for multiple arm therapy trial and then refractory tumors implanted for additional multiple arm therapy trial
transcription profiling by array
David Cherba <firstname.lastname@example.org>, David M Cherba, Noel R Monks
Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistance. Monsma DJ, Cherba DM, Richardson PJ, Vance S, Rangarajan S, Dylewski D, Eugster E, Scott SB, Beuschel NL, Davidson PJ, Axtell R, Mitchell D, Lester EP, Junewick JJ, Webb CP, Monks NR. , PMID:24687871